Navigation Links
Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
Date:10/12/2011

EAST BRUNSWICK, N.J., Oct. 12, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the company will release financial results for the third quarter 2011 prior to the open of the market on Thursday, November 3, 2011.

John H. Johnson, Chief Executive Officer and President, and Kenneth J. Zuerblis, Executive Vice President and Chief Financial Officer, will host an investment community conference call beginning at 9:00 a.m. Eastern Time on November 3, 2011 to discuss these results and to answer questions.

To participate by telephone, please dial 866-393-9370 (Domestic) or 706-679-1207 (International). The conference ID number is 17722127. The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com. Please log on to Savient's website fifteen minutes prior to the start of the call to ensure adequate time for any downloads that may be necessary.

A telephone replay will be available from 12:00 p.m. Eastern Time on November 3, 2011 through 12:00 a.m. Eastern Time on November 17, 2011 by dialing 855-859-2056 (Domestic), alternate number 800-585-8367 or 404-537-3406 (International) and entering conference ID number 17722127.

About Savient Pharmaceuticals, Inc.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA.  MVP and Duke have been grant
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)...  Hill-Rom Holdings, Inc. (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 8, ... invited to listen to the live discussion via the ... directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of ... of the live event and accessible at the links ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting ... prestigious R&D 100 Award for the new OSRAM ITOS ® ... LED-based white light module for microscopy, endoscopy and surgical head ... with significantly higher efficacy and lamp life. "We,re ... one of the most innovative new technologies of the past ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... Drug Administration (FDA) has granted priority review designation for ... Ivabradine is an oral drug that inhibits the ... sinoatrial node, the body,s cardiac pacemaker. 1 Ivabradine ... on myocardial contractility or ventricular repolarization. 1 Heart ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... President and Chief Executive Officer, will present at ... the Westin St. Francis Hotel in San Francisco, ... PT. About Omthera Pharmaceuticals, Inc.Founded ...
... Medical Technologies, Inc. today announced that Allina Hospitals ... company,s integrated electronic health record (EHR) practice management ... across Minnesota and western Wisconsin. ... ability to interface tightly with Allina,s Epic-based electronic ...
Cached Medicine Technology:Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 2Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 3
(Date:8/28/2014)... MarijuanaDoctors.com is enthralled to announce the addition ... Livermore, California. As always, MarijuanaDoctors.com prides itself on affiliating ... in accordance with that, we are excited to introduce ... , Initially finding his calling for healing and interest ... shaped by his mother’s severe arthritis to finally become ...
(Date:8/28/2014)... Texas (PRWEB) August 28, 2014 The need ... growth over the past few years. The new location - ... offer higher quality and larger office space than TLC had ... , “We are pleased about our new location because ... “While our suite will be double in size compared to ...
(Date:8/27/2014)... Villanova, PA (PRWEB) August 28, 2014 ... (published by iUniverse) takes readers on the thrilling adventures ... The book, published in 2012, is gearing up for ... 2014. , Split into two novellas , “Prescription: ... orthopedic surgeon who finds himself dodging assassination attempts and ...
(Date:8/27/2014)... Recently, BambooIndustry.com, an innovative company that provides many kinds of ... panels are now offered on its website. In addition, ... All people that place an order for its newly released ... percent off. , The company’s senior spokesman was excited ... our new and old customers can buy cheap bamboo panels ...
(Date:8/27/2014)... National Resident Matching Program International ... Medical Education in Europe (AMEE) Conference being held at ... – September 3, 2014. As an exhibitor, NRMPI ... community, share the benefits of its matching services, and ... in countries throughout the world. , “Exhibiting ...
Breaking Medicine News(10 mins):Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... 23 James. G. Schwade, M.D. announces the newly enhanced CyberKnife ... ( www.cyberknifemiami.com ). , The CyberKnife treatment for cancer ... cells with no invasive surgical incision. The length of the ... usually completed in 1- 5 treatments. , As the ...
... 20 percent get infected within one year of starting to ... News) -- As many as one in four U.S. teenage ... soon after their first sexual encounter, a new government report ... reminds us that we can,t ignore this," said study author ...
... is leading an initiative that could result in a paradigm ... Morehouse University School of Medicine and University of ... care physicians across Georgia to serve as "medical homes" for ... sends them to the hospital and seeking better prevention and ...
... , ... Instacare Corp. (OTC Bulletin Board: ISCR) announced today that its ... e-health technologies have been successfully engineered to seamlessly function on ... hand-held interactive medical software to the Apple iPhone, the Palm ...
... , NEW ORLEANS, Nov. 23 Thanksgiving weekend marks the 36th annual ... the sportsmanship and pride of two schools but it is so much ... in attendance. , For the crew of the new U.S. Coast Guard ... before they work to test and launch a brand new ship to ...
... ... and Automate Billing, Claims, Enrollment and Eligibility, , ... (PRWEB) November 23, 2009 -- BridgeGate ... the launch of new products within its healthcare integration suite, designed to help ...
Cached Medicine News:Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:Nothing Is Like Being There 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: